• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number UNK758
Device Problems Fracture (1260); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Cardiogenic Shock (2262)
Event Date 03/22/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.  (b)(4).The device was not received for analysis.The investigation conclusion is device not returned as the complaint did not include returned device review and lacked the objective evidence or descriptive conditions of the event required to determine what could have contributed to the event.  (b)(4).
 
Event Description
Same case as mdr id: 2134265-2018-04194.(b)(4) clinical study.It was reported that cardiogenic shock and stent fracture occurred.In (b)(6) 2017, the patient presented emergently with complaints of midsternal chest pain and hypoxia, which improved with medications in the emergency.Physical examination revealed regular rhythm and systolic murmur.The patient was hospitalized for further evaluation and management.At the time of the event, the patient was on baby aspirin and lasix which were continued further.Electrocardiogram (ecg) revealed marked st abnormality due to possible lateral subendocardial injury.Chest x ray revealed elevated right diaphragm.Cardiac enzymes were elevated consistent with protocol definition of myocardial infarction.The patient was diagnosed with non-st segment elevation acute coronary syndrome.The following day, ecg revealed left ventricular hypertrophy with repolarization abnormality and t wave inversion.Three days from hospitalization, selective coronary angiography was performed which revealed 80% stenosis in left main coronary artery (lmca).The lesion was treated with placement of a 3x12mm promus stent and 60% stenosis in proximal left anterior descending artery(lad) which was intervened with a 3x16mm promus stent.Subsequently, retroperitoneal bleeding was noted at the site of coronary catheterization.Drop in hemoglobin level was also observed with acute blood loss anemia.The patient was transfused with 6 units of packed red blood cells ( prbc) post which hemoglobin level was stable.Valve academic research consortium (varc) bleeding classification was life threatening or disabling.Computed tomography scan of abdomen revealed right retroperitoneal hemorrhage measuring approximately 16x3x6cm in size.The vascular event was related to the major bleed retroperitoneal bleed post percutaneous coronary intervention heart catheterization.One day post procedure, excimer laser coronary atherectomy of the lmca was planned.During the procedure, a stent fracture was noted in the lmca due to which the laser catheter (manufacturer unknown) was unable to pass beyond the stent.Furthermore, an angioplasty with angioscope balloon was performed in the mid to distal lmca and the proximal lad.Then, it was finally treated with balloon angioplasty.Subsequently, angiography demonstrated grade iii timi flow.Post stent support angioplasty, the post operative care was complicated and the subject developed cardiogenic shock.The patient was transferred to intensive care unit (icu) for further management and care.Within several days, the patient¿s condition improved; hence, the patient was transferred to the floor.A week after, the bleeding complication and vascular complications were considered to be recovered/ resolved and the patient was discharged home.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that adjudication indicated myocardial infarction, bleeding complication and vascular complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7519136
MDR Text Key108425142
Report Number2134265-2018-04193
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNK758
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/25/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age78 YR
-
-